List of bibliographic references
Number of relevant bibliographic references: 14.
Ident. | Authors (with country if any) | Title |
---|
000019 (2014) |
Nir Giladi ; Liesbet Ghys ; Erwin Surmann ; Babak Boroojerdi ; Joseph Jankovic | Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson's disease. |
000040 (2014) |
Rajesh Pahwa ; Kelly. Lyons ; Robert. Hauser ; Stanley Fahn ; Joseph Jankovic ; Emmanuelle Pourcher ; Ann Hsu ; Martin O ; Sherron Kell ; Suneel Gupta | Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease. |
000064 (2012) |
Andrew Lees ; Stanley Fahn ; Karla. Eggert ; Joseph Jankovic ; Anthony Lang ; Federico Micheli ; M Mouradian ; Wolfgang. Oertel ; C Olanow ; Werner Poewe ; Olivier Rascol ; Eduardo Tolosa ; David Squillacote ; Dinesh Kumar | Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease. |
000099 (2010) |
Rodger. Elble ; Oksana Suchowersky ; Stephanie Shaftman ; William. Weiner ; Peng Huang ; Barbara Tilley | Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease. |
000106 (2009) |
C Olanow ; Olivier Rascol ; Robert Hauser ; Paul. Feigin ; Joseph Jankovic ; Anthony Lang ; William Langston ; Eldad Melamed ; Werner Poewe ; Fabrizio Stocchi ; Eduardo Tolosa | A double-blind, delayed-start trial of rasagiline in Parkinson's disease. |
000131 (2008) |
C Olanow ; Robert. Hauser ; Joseph Jankovic ; William Langston ; Anthony Lang ; Werner Poewe ; Eduardo Tolosa ; Fabrizio Stocchi ; Eldad Melamed ; Eli Eyal ; Olivier Rascol | A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics. |
000153 (????) |
Peter. Lewitt ; Babak Boroojerdi ; Douglas Macmahon ; James Patton ; Joseph Jankovic | Overnight switch from oral dopaminergic agonists to transdermal rotigotine patch in subjects with Parkinson disease. |
000160 (2007) |
James. Sheffield ; Joseph Jankovic | Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease. |
000162 (2007) |
Joseph Jankovic ; Ray. Watts ; Wayne Martin ; Babak Boroojerdi | Transdermal rotigotine: double-blind, placebo-controlled trial in Parkinson disease. |
000186 (2005) |
Tianhong Pan ; Xinqun Li ; Wenjie Xie ; Joseph Jankovic ; Weidong Le | Valproic acid-mediated Hsp70 induction and anti-apoptotic neuroprotection in SH-SY5Y cells. |
000199 (2005) |
C Olanow ; Joseph Jankovic | Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy. |
000202 (2005) |
Tianhong Pan ; Wenjie Xie ; Joseph Jankovic ; Weidong Le | Biological effects of pramipexole on dopaminergic neuron-associated genes: relevance to neuroprotection. |
000252 (2001) |
P Hanna ; L. Ratkos ; W Ondo ; J. Jankovic | Switching from pergolide to pramipexole in patients with Parkinson's disease. |
000346 (1982) |
J. Jankovic | Management of motor side effects of chronic levodopa therapy. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/PubMed/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Dose-Response Relationship, Drug"
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i \
-Sk "Dose-Response Relationship, Drug" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= JankovicV1
|flux= PubMed
|étape= Corpus
|type= indexItem
|index= MedMesh.i
|clé= Dose-Response Relationship, Drug
}}
| This area was generated with Dilib version V0.6.19. Data generation: Wed Feb 10 22:03:07 2016. Site generation: Tue Feb 13 16:14:27 2024 | |